These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36795782)

  • 1. Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor.
    Akins NS; Salahuddin MF; Pandey P; Kim SJ; Mahdi F; Khan MIH; Moss EM; Worth CJ; Keane MM; Chittiboyina AG; Doerksen RJ; Paris JJ; Le HV
    ACS Chem Neurosci; 2023 Mar; 14(5):958-976. PubMed ID: 36795782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
    Jackson KJ; Jackson A; Carroll FI; Damaj MI
    Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
    Schank JR; Goldstein AL; Rowe KE; King CE; Marusich JA; Wiley JL; Carroll FI; Thorsell A; Heilig M
    Addict Biol; 2012 May; 17(3):634-47. PubMed ID: 22515275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.
    Jackson KJ; Carroll FI; Negus SS; Damaj MI
    Psychopharmacology (Berl); 2010 Jun; 210(2):285-94. PubMed ID: 20232057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake.
    Schlosburg JE; Whitfield TW; Park PE; Crawford EF; George O; Vendruscolo LF; Koob GF
    J Neurosci; 2013 Dec; 33(49):19384-92. PubMed ID: 24305833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders.
    Reed B; Butelman ER; Kreek MJ
    Handb Exp Pharmacol; 2022; 271():473-491. PubMed ID: 33174064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
    Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
    Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats.
    Beardsley PM; Howard JL; Shelton KL; Carroll FI
    Psychopharmacology (Berl); 2005 Nov; 183(1):118-26. PubMed ID: 16184376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
    Xie JY; De Felice M; Kopruszinski CM; Eyde N; LaVigne J; Remeniuk B; Hernandez P; Yue X; Goshima N; Ossipov M; King T; Streicher JM; Navratilova E; Dodick D; Rosen H; Roberts E; Porreca F
    Cephalalgia; 2017 Jul; 37(8):780-794. PubMed ID: 28376659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.
    van de Wetering R; Ewald A; Welsh S; Kornberger L; Williamson SE; McElroy BD; Butelman ER; Prisinzano TE; Kivell BM
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. κ opioid regulation of anxiety-like behavior during acute ethanol withdrawal.
    Valdez GR; Harshberger E
    Pharmacol Biochem Behav; 2012 Jul; 102(1):44-7. PubMed ID: 22487769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.
    Munro TA; Berry LM; Van't Veer A; Béguin C; Carroll FI; Zhao Z; Carlezon WA; Cohen BM
    BMC Pharmacol; 2012 May; 12():5. PubMed ID: 22642416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.
    Valenza M; Windisch KA; Butelman ER; Reed B; Kreek MJ
    Psychopharmacology (Berl); 2020 Apr; 237(4):1147-1160. PubMed ID: 31915862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
    Gillett K; Harshberger E; Valdez GR
    Alcohol; 2013 Aug; 47(5):359-65. PubMed ID: 23731692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.
    Munro TA; Huang XP; Inglese C; Perrone MG; Van't Veer A; Carroll FI; Béguin C; Carlezon WA; Colabufo NA; Cohen BM; Roth BL
    PLoS One; 2013; 8(8):e70701. PubMed ID: 23976952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa opioid regulation of depressive-like behavior during acute withdrawal and protracted abstinence from ethanol.
    Jarman SK; Haney AM; Valdez GR
    PLoS One; 2018; 13(9):e0205016. PubMed ID: 30265734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.
    Hutsell BA; Cheng K; Rice KC; Negus SS; Banks ML
    Addict Biol; 2016 Mar; 21(2):360-73. PubMed ID: 25581305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.